Skip to main content
SpringerLink
Log in

Association Between Circulating Copeptin Level and Mortality Risk in Patients with Intracerebral Hemorrhage: a Systemic Review and Meta-Analysis

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Copeptin has been identified as a biomarker of disease severity and is associated with mortality risk in several common diseases. This study sought to determine the association between circulating copeptin level and mortality risk in patients with intracerebral hemorrhage. PubMed, Web of Science, and Wanfang Medicine Database were searched for studies assessing the association between circulating copeptin level and mortality risk in patients with intracerebral hemorrhage. The pooled hazard ratio (HR) of mortality was calculated and presented with 95 % confidence interval (95 % CI). Data from 1332 intracerebral hemorrhage patients were derived from 9 studies. Meta-analysis showed that intracerebral hemorrhage patients with poor prognosis had much higher copeptin levels than those survivors (standardized mean difference = 1.68, 95 % CI 1.26–2.11, P < 0.00001). Meta-analysis of 8 studies with HRs showed that high circulating copeptin level was associated with higher risk of mortality in patients with intracerebral hemorrhage (HR = 2.42, 95 % CI 1.60–3.65, P < 0.0001). Meta-analysis of 6 studies with adjusted HRs showed that high circulating copeptin level was independently associated with higher risk of mortality in patients with intracerebral hemorrhage (HR = 1.67, 95 % CI 1.26–2.22, P = 0.0003). Our study suggests that there is an obvious association between circulating copeptin level and mortality in patients with intracerebral hemorrhage. High circulating copeptin level is independently associated with higher risk of mortality in patients with intracerebral hemorrhage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ikram MA, Wieberdink RG, Koudstaal PJ (2012) International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 14(4):300–306

    Article  PubMed  PubMed Central  Google Scholar 

  2. Provencio JJ, Da Silva IR, Manno EM (2013) Intracerebral hemorrhage: new challenges and steps forward. Neurosurg Clin N Am 24(3):349–359

    Article  PubMed  Google Scholar 

  3. Kreitzer N, Adeoye O (2013) An update on surgical and medical management strategies for intracerebral hemorrhage. Semin Neurol 33(5):462–467

    Article  PubMed  Google Scholar 

  4. Brouwers HB, Greenberg SM (2013) Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis 35(3):195–201

    Article  PubMed  PubMed Central  Google Scholar 

  5. Brunswick AS, Hwang BY, Appelboom G, Hwang RY, Piazza MA, Connolly ES Jr (2012) Serum biomarkers of spontaneous intracerebral hemorrhage induced secondary brain injury. J Neurol Sci 321(1-2):1–10

    Article  CAS  PubMed  Google Scholar 

  6. Marginean IC, Stanca DM, Vacaras V, Soritau O, Margiean M, Muresanu DF (2011) Plasmatic markers in hemorrhagic stroke. J Med Life 4(2):148–150

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Ovesen C, Havsteen I, Rosenbaum S, Christensen H (2014) Prediction and observation of post-admission hematoma expansion in patients with intracerebral hemorrhage. Front Neurol 5186

  8. Kleindienst A, Brabant G, Morgenthaler NG, Dixit KC, Parsch H, Buchfelder M (2010) Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity. Acta Neurochir Suppl 106221–224

  9. Zhang J, Zhang CH, Lin XL, Zhang Q, Wang J, Shi SL (2013) Serum glial fibrillary acidic protein as a biomarker for differentiating intracerebral hemorrhage and ischemic stroke in patients with symptoms of acute stroke: a systematic review and meta-analysis. Neurol Sci 34(11):1887–1892

    Article  CAS  PubMed  Google Scholar 

  10. Bolignano D, Cabassi A, Fiaccadori E, Ghigo E, Pasquali R, Peracino A, Peri A, Plebani M et al (2014) Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med 52(10):1447–1456

    Article  CAS  PubMed  Google Scholar 

  11. Yalta K, Yalta T, Sivri N, Yetkin E (2013) Copeptin and cardiovascular disease: a review of a novel neurohormone. Int J Cardiol 167(5):1750–1759

    Article  PubMed  Google Scholar 

  12. Anand T, Skinner R (2012) Arginine vasopressin: the future of pressure-support resuscitation in hemorrhagic shock. J Surg Res 178(1):321–329

    Article  CAS  PubMed  Google Scholar 

  13. Ueta Y, Dayanithi G, Fujihara H (2011) Hypothalamic vasopressin response to stress and various physiological stimuli: visualization in transgenic animal models. Horm Behav 59(2):221–226

    Article  CAS  PubMed  Google Scholar 

  14. Then C, Kowall B, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Rathmann W et al (2015) Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study. Acta Diabetol 52(1):103–112

    Article  CAS  PubMed  Google Scholar 

  15. Then C, Kowall B, Lechner A, Meisinger C, Heier M, Koenig W, Peters A, Thiery J et al (2013) Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study. Cardiovasc Diabetol 12168

  16. Bar-Shalom D, Poulsen MK, Rasmussen LM, Diederichsen AC, Sand NP, Henriksen JE, Nybo M (2014) Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients. Diab Vasc Dis Res 11(6):448–450

    Article  CAS  PubMed  Google Scholar 

  17. Mockel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C et al (2015) Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 36(6):369–376

    Article  PubMed  Google Scholar 

  18. De Marchis GM, Katan M, Weck A, Brekenfeld C, Mattle HP, Buhl D, Muller B, Christ-Crain M et al (2013) Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study. Int J Stroke 8(3):214–218

    Article  PubMed  Google Scholar 

  19. Zweifel C, Katan M, Schuetz P, Siegemund M, Morgenthaler NG, Merlo A, Mueller B, Christ-Crain M (2010) Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol 1034

  20. Yu WH, Wang WH, Dong XQ, Du Q, Yang DB, Shen YF, Wang H, Zhang ZY et al (2014) Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage. Clin Chim Acta 433174–178

  21. Zhu XD, Chen JS, Zhou F, Liu QC, Chen G, Zhang JM (2011) Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage. Crit Care 15(6):R288

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zhang A, Li J, Li X, Song L, Li H (2013) The prognostic value of copeptin for acute intracerebral hemorrhage patients. Exp Ther Med 5(2):467–470

    CAS  PubMed  Google Scholar 

  23. Wei ZJ, Ou YQ, Li X, Li H (2014) The 90-day prognostic value of copeptin in acute intracerebral hemorrhage. Neurol Sci 35(11):1673–1679

    Article  PubMed  Google Scholar 

  24. Zhang X, Lu XM, Huang LF, Ye H (2012) Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage. Peptides 33(2):336–341

    Article  CAS  PubMed  Google Scholar 

  25. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269, W264

    Article  PubMed  Google Scholar 

  26. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site

  27. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

    CAS  PubMed  Google Scholar 

  28. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  PubMed  Google Scholar 

  29. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  PubMed Central  Google Scholar 

  30. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  CAS  PubMed  Google Scholar 

  32. Yang DB, Yu WH, Dong XQ, Du Q, Shen YF, Zhang ZY, Zhu Q, Che ZH et al (2014) Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury. Peptides 5826–29

  33. Fung C, De Marchis GM, Katan M, Seiler M, Arnold M, Gralla J, Raabe A, Beck J (2013) Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. PLoS One 8(1), e53191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Dong XQ, Huang M, Yu WH, Zhang ZY, Zhu Q, Che ZH, Du Q, Wang H (2011) Change in plasma copeptin level after acute spontaneous basal ganglia hemorrhage. Peptides 32(2):253–257

    Article  CAS  PubMed  Google Scholar 

  35. Wu ZX, Yu WH, Dong XQ (2013) Correlation of plasma copeptin levels with long term prognosis of patients with intracerebral hemorrhage [article in Chinese]. Zhejiang Med J 35(17):1557–1560

    CAS  Google Scholar 

  36. Liu YF, Zhao XQ (2013) Biomarkers and imaging in hemorrhagic stroke and clinical prognosis [unpublished article]. Wanfang Doctoral Dissertation 2013(Capital Medical University): 2013

  37. Bian LH, Zhao XQ (2013) Neuroendocrine and prognosis of patients with aneurysmal subarachnoid hemorrhage [unpublished article]. Wanfang Doctoral Dissertation 2013(Capital Medical University): 2013

  38. Iversen K, Gotze JP, Dalsgaard M, Nielsen H, Boesgaard S, Bay M, Kirk V, Nielsen OW et al (2014) Risk stratification in emergency patients by copeptin. BMC Med 1280

  39. Lipinski MJ, Escarcega RO, D’Ascenzo F, Magalhaes MA, Baker NC, Torguson R, Chen F, Epstein SE et al (2014) A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am J Cardiol 113(9):1581–1591

    Article  CAS  PubMed  Google Scholar 

  40. Nickel NP, Lichtinghagen R, Golpon H, Olsson KM, Brand K, Welte T, Hoeper MM (2013) Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension. Respir Res 14130

  41. Sun H, Sun T, Ma B, Yang BW, Zhang Y, Huang DH, Shi JP (2015) Prediction of all-cause mortality with copeptin in cardio-cerebrovascular patients: a meta-analysis of prospective studies. Peptides 699–18

  42. Hertz L, Xu J, Chen Y, Gibbs ME, Du T (2014) Antagonists of the vasopressin V1 receptor and of the beta(1)-adrenoceptor inhibit cytotoxic brain edema in stroke by effects on astrocytes—but the mechanisms differ. Curr Neuropharmacol 12(4):308–323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Pascale CL, Szmydynger-Chodobska J, Sarri JE, Chodobski A (2006) Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1a receptor. J Physiol Pharmacol 57(Suppl):11161–11167

    Google Scholar 

Download references

Acknowledgments

The authors wish to thank all the colleagues for their participation and support. This study was supported by Natural Science Foundation for the Youth (No. 81100241).

Author information

Authors and Affiliations

  1. Department of Geriatrics, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, People’s Republic of China

    Ruoyu Zhang, Jin Liu, Qiang Liu & Tianlang Li

  2. Neuroscience Care Unit, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China

    Ying Zhang

  3. Department of Neurosurgery, The Affiliated Hospital of Shandong University, Jinan, 250019, China

    Lei Cheng

Authors
  1. Ruoyu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tianlang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lei Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ruoyu Zhang.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, R., Liu, J., Zhang, Y. et al. Association Between Circulating Copeptin Level and Mortality Risk in Patients with Intracerebral Hemorrhage: a Systemic Review and Meta-Analysis. Mol Neurobiol 54, 169–174 (2017). https://doi.org/10.1007/s12035-015-9626-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-015-9626-z

Keywords

Search

Navigation